Literature DB >> 15027000

Rotavirus typing methods and algorithms.

Thea K Fischer1, Jon R Gentsch.   

Abstract

Vaccination is the current strategy for control and prevention of severe rotavirus infections, a major cause of acute, dehydrating diarrhoea in young children worldwide. Public health interventions aimed at improving water, food and sanitation are unlikely adequately to control the disease. The development of vaccines against severe rotavirus diarrhoea is based upon homotypic or heterotypic protection provided against either a single common G serotype (monovalent vaccines) or against multiple serotypes (multivalent vaccines). Rotavirus strain surveillance has a high priority in disease control programmes worldwide. The continued identification of the most common G and P serotypes for inclusion in vaccines is an important priority. And subsequent to the introduction of a vaccine candidate, not only monitoring of circulating strains is recommended, but also surveillance of potential reassortment of animal rotavirus genes from the vaccine into human rotavirus strains is critical. Conventional methods used in the characterisation of rotavirus strains, such as enzyme immunoassay serotyping and reverse-transcription PCR-based genotyping often fail to identify uncommon and newly appearing strains. The application of newer molecular approaches, including sequencing and oligonucleotide microarray hybridisation, may be required to characterise such strains. The present paper presents a brief overview of the variety of standard methods available, followed by suggestions for a systematic approach for routine rotavirus strain surveillance as well as for characterisation of incompletely typed rotavirus strains. Improved detection and characterisation of incompletely typed strains will help to develop a comprehensive strain surveillance that may be required for tailoring effective rotavirus vaccines.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15027000      PMCID: PMC7169166          DOI: 10.1002/rmv.411

Source DB:  PubMed          Journal:  Rev Med Virol        ISSN: 1052-9276            Impact factor:   6.989


  98 in total

Review 1.  Structural studies on gastroenteritis viruses.

Authors:  B V Prasad; S Crawford; J A Lawton; J Pesavento; M Hardy; M K Estes
Journal:  Novartis Found Symp       Date:  2001

2.  Identification of gene 4 alleles among human rotaviruses by polymerase chain reaction-derived probes.

Authors:  G Larralde; J Flores
Journal:  Virology       Date:  1990-11       Impact factor: 3.616

3.  Sequence analysis of gene 11 equivalents from "short" and "super short" strains of rotavirus.

Authors:  S M Matsui; E R Mackow; S Matsuno; P S Paul; H B Greenberg
Journal:  J Virol       Date:  1990-01       Impact factor: 5.103

4.  Comparison of enzyme immunoassay, PCR, and type-specific cDNA probe techniques for identification of group A rotavirus gene 4 types (P types).

Authors:  P J Masendycz; E A Palombo; R J Gorrell; R F Bishop
Journal:  J Clin Microbiol       Date:  1997-12       Impact factor: 5.948

5.  Comparative studies of human rotavirus serotype G8 strains recovered in South Africa and the United Kingdom.

Authors:  A D Steele; S P Parker; I Peenze; C T Pager; M B Taylor; W D Cubitt
Journal:  J Gen Virol       Date:  1999-11       Impact factor: 3.891

6.  Characterization of the G serotype and genogroup of New Delhi newborn rotavirus strain 116E.

Authors:  B K Das; J R Gentsch; Y Hoshino; S Ishida; O Nakagomi; M K Bhan; R Kumar; R I Glass
Journal:  Virology       Date:  1993-11       Impact factor: 3.616

7.  Unusual diversity of human rotavirus G and P genotypes in India.

Authors:  M Ramachandran; B K Das; A Vij; R Kumar; S S Bhambal; N Kesari; H Rawat; L Bahl; S Thakur; P A Woods; R I Glass; M K Bhan; J R Gentsch
Journal:  J Clin Microbiol       Date:  1996-02       Impact factor: 5.948

8.  Evaluation of a reassortant rhesus rotavirus vaccine in young children.

Authors:  T Tajima; J Thompson; P F Wright; Y Kondo; S J Tollefson; J King; A Z Kapikian
Journal:  Vaccine       Date:  1990-02       Impact factor: 3.641

9.  Randomised placebo-controlled trial of rhesus-human reassortant rotavirus vaccine for prevention of severe rotavirus gastroenteritis.

Authors:  J Joensuu; E Koskenniemi; X L Pang; T Vesikari
Journal:  Lancet       Date:  1997-10-25       Impact factor: 79.321

10.  Detection of rotavirus in faeces by latex agglutination.

Authors:  T Sanekata; Y Yoshida; H Okada
Journal:  J Immunol Methods       Date:  1981       Impact factor: 2.303

View more
  11 in total

1.  Predominance of rotavirus genotype G9 during the 1999, 2000, and 2002 seasons among hospitalized children in the city of Salvador, Bahia, Brazil: implications for future vaccine strategies.

Authors:  Norma Santos; Eduardo M Volotão; Caroline C Soares; Gúbio S Campos; Silvia Ines Sardi; Yasutaka Hoshino
Journal:  J Clin Microbiol       Date:  2005-08       Impact factor: 5.948

2.  Development of a microtiter plate hybridization-based PCR-enzyme-linked immunosorbent assay for identification of clinically relevant human group A rotavirus G and P genotypes.

Authors:  Norma Santos; Shinjiro Honma; Maria do Carmo S T Timenetsky; Alexandre C Linhares; Hiroshi Ushijima; George E Armah; Jon R Gentsch; Yasutaka Hoshino
Journal:  J Clin Microbiol       Date:  2007-12-05       Impact factor: 5.948

3.  Development and validation of DNA microarray for genotyping group A rotavirus VP4 (P[4], P[6], P[8], P[9], and P[14]) and VP7 (G1 to G6, G8 to G10, and G12) genes.

Authors:  Shinjiro Honma; Vladimir Chizhikov; Norma Santos; Masatoshi Tatsumi; Maria do Carmo S T Timenetsky; Alexandre C Linhares; Joana D'Arc P Mascarenhas; Hiroshi Ushijima; George E Armah; Jon R Gentsch; Yasutaka Hoshino
Journal:  J Clin Microbiol       Date:  2007-06-13       Impact factor: 5.948

4.  Detection of rotavirus in clinical specimens using an immunosensor prototype based on the photon burst counting technique.

Authors:  Makoto Hasegawa; Ernest Apondi Wandera; Yuka Inoue; Nanami Kimura; Ryuzo Sasaki; Tamio Mizukami; Mohammad Monir Shah; Nobuaki Shirai; Osamu Takei; Hironori Shindo; Yoshio Ichinose
Journal:  Biomed Opt Express       Date:  2017-06-23       Impact factor: 3.732

5.  Etiology of acute gastroenteritis in children requiring hospitalization in the Netherlands.

Authors:  I H M Friesema; R F de Boer; E Duizer; L M Kortbeek; D W Notermans; O F Norbruis; D D L Bezemer; H van Heerbeek; R N J van Andel; J G van Enk; P L A Fraaij; M P G Koopmans; A M D Kooistra-Smid; Y T H P van Duynhoven
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2011-07-03       Impact factor: 3.267

6.  Emergence of G12 rotavirus strains in Delhi, India, in 2000 to 2007.

Authors:  S Sharma; P Ray; J R Gentsch; R I Glass; V Kalra; M K Bhan
Journal:  J Clin Microbiol       Date:  2008-02-13       Impact factor: 5.948

7.  Multiplexed one-step RT-PCR VP7 and VP4 genotyping assays for rotaviruses using updated primers.

Authors:  Mathew D Esona; Rashi Gautam; Ka Ian Tam; Alice Williams; Slavica Mijatovic-Rustempasic; Michael D Bowen
Journal:  J Virol Methods       Date:  2015-07-29       Impact factor: 2.014

8.  Distribution of Rotavirus Genotypes Ccirculating zzm321990in Ahvaz, Iran in 2016

Authors:  Azarakhsh Azaran; Manoochehr Makvandi; Ali Teimoori; Saeedeh Ebrahimi; Farzad Heydari; Roya Nikfar
Journal:  Iran Biomed J       Date:  2017-09-16

9.  Inaccurate identification of rotavirus genotype G9 as genotype G3 strains due to primer mismatch.

Authors:  Marcelo Takahiro Mitui; Tga Nilmini Chandrasena; Paul Ks Chan; Shaman Rajindrajith; E Anthony S Nelson; Ting Fan Leung; Akira Nishizono; Kamruddin Ahmed
Journal:  Virol J       Date:  2012-08-03       Impact factor: 4.099

10.  One-step multiplex real-time RT-PCR assay for detecting and genotyping wild-type group A rotavirus strains and vaccine strains (Rotarix® and RotaTeq®) in stool samples.

Authors:  Rashi Gautam; Slavica Mijatovic-Rustempasic; Mathew D Esona; Ka Ian Tam; Osbourne Quaye; Michael D Bowen
Journal:  PeerJ       Date:  2016-01-11       Impact factor: 2.984

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.